Medroxyprogesterone Acetate Tablet — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Medroxyprogesterone Acetate Tablet (tablet) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Aug 31, 2026.

Shortage details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0009-0051-01
Dosage Form
Tablet
Presentation
PROVERA, Tablet, 10 mg (NDC 0009-0051-01)
Initial Posting
Aug 31, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.